Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- PTC Therapeutics, Inc.
- Rocket Pharmaceuticals, Inc.
Updated Jul 16, 2026
SOUTHWELL DAVID P has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $700K.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 22.9K | $0.00 | |
| 2025-09-09 | PTCT | PTC THERAPEUTICS, INC. | S — Open-market sale | 12.0K | $58.34 | $700K |
| 2025-09-09 | PTCT | PTC THERAPEUTICS, INC. | M — Option exercise | 12.0K | $30.86 | $370K |
| 2025-06-18 | RCKT | ROCKET PHARMACEUTICALS, INC. | A — Grant or award | 30.0K | $0.00 |
SOUTHWELL DAVID P is a corporate insider — currently tracked as Insider of ROCKET PHARMACEUTICALS, INC. (RCKT). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 1 open-market sales ($700K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live SOUTHWELL DAVID P profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.